Lol, yeah, don’t announce any new ideas like that until it get approved... leronlimab is the only drug in the Ccr5 inhibitor class without the serious side effects. I think the fda is just being very careful, wanting to double check with the 700mg safety data. They have 800+ patients that took it now, should ease the mind of the worrywart fda.